Recombinant Dna Technology Market Growth Driven By Fact That Increasing Technological Advancements Facilitating The Production Of Novel Products And Key Players Are Pfizer Inc., Scientific Inc., Biogen Inc., Sanofi Pasteur, Merck & Co., Inc.

Recombinant DNA technology has allowed the transfer of desired characteristics which is useful to improve the existing systems by controlling expression of target genes. Recombinant DNA technology allows mass production of therapeutic proteins, which are characterized by high level of consistency and stability. The technology has multidisciplinary applications and potential to deal with important aspects of life, for instance, improving health, and enhancing food resources. The genetically modified plants have augmented resistance to viruses and insect attacks, enhanced product yield, and shown increased adaptability for better survival. The global recombinant DNA technology market was valued at US$ 106.8 billion in 2017, and is expected to exhibit a robust CAGR of 7.9% over the forecast period (2017 – 2025).

Get PDF Brochure of Research Report : https://www.coherentmarketinsights.com/insight/request-pdf/893

"Recombinant Dna Technology - Market Dynamics"

Rapid technological advancements in the field of genetic engineering to deliver highly efficient therapeutics for disease management and in the field of agriculture are major driving factors for growth of recombinant DNA technology market. For instance, Bac-to-Bac Baculovirus Expression Systems offers a quick and efficient method to produce recombinant baculovirus and can express the desired genes in insect cells and provide high yields of recombinant protein that speeds up the cloning reaction as compared to the time-consuming restriction enzyme cloning, which takes 2–3 days. Also, in 2016, a BioAg Alliance was formed between Monsanto and Novozymes A/S, to improve crop harvests by using products containing naturally-occurring microbes to boost agricultural productivity and expand its product portfolio. However, the adoption of non-biologic therapeutics and higher complexity of the genetically engineered products such as stability of the cell lines, requirement of skilled professionals, and optimum temperature are the factors hindering the market growth.

Key features of the study:

-This report provides in-depth analysis of recombinant DNA technology market and provides market size (US$ Billion) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2016 as the base year
-It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
-This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
-It profiles leading players in the global recombinant DNA technology market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, and strategies, and future plans
-Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., Biogen, Inc., Sanofi Pasteur, Merck & Co., Inc., Pfizer, Inc., Profacgen, Amgen, Inc., and Monsanto Company

Speak to Analyst Before Purchasing This Report: https://www.coherentmarketinsights.com/insight/talk-to-analyst/893

"Recombinant Dna Technology Market Taxanomy"

Detailed Segmentation:

Global Recombinant DNA Technology Market, By Product Type:

Recombinant Protein Drugs
-Insulin
-Human Growth Hormone
-Erythropoietin
-Interferon
-Blood Factors
-Colony Stimulating Factors
-Fusion Proteins
-Others

Vaccines
Genetically Modified Crops
Expression Systems
-Prokaryotic Cells
-Mammalian Cells
-Yeats
-Insect
-Others
Cell and Gene Therapy
Gene Editing

Global Recombinant DNA Technology Market, By Application:
-Therapeutics
-Agriculture
-Research

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.